The impact of insulin resistance and NAFLD after liver transplantation on patient survival and development of chronic kidney disease
| Autor: | Irena Míková, Denisa Kyselová, Kateřina Dvořáková, Monika Dezortová, Milan Hájek, Monika Cahová, Helena Daňková, Věra Lánská, Julius Špičák, Pavel Trunečka |
|---|---|
| Rok vydání: | 2022 |
| Předmět: | |
| Zdroj: | Gastroenterologie a hepatologie. 76:429-441 |
| ISSN: | 1804-803X 1804-7874 |
| Popis: | Summary: Introduction: Insulin resistance (IR) is a hallmark of non-alcoholic fatty liver disease (NAFLD), which has been associated with worse long-term survival and more frequent occurrence of chronic kidney disease (CKD) than in patients without NAFLD. The aim of our study was to evaluate the impact of NAFLD and IR on survival and renal function in patients after liver transplantation (LT). Methods: Our prospective study included 96 LT candidates who were observed after LT. We evaluated patient survival and occurrence of CKD (defined as estimated glomerular filtration [eGFR] ≤1.00 mL/s/1.73 m2 or overt proteinuria) 5 years after LT and at the end of follow-up. Clinical, laboratory, MR and elastographic evaluation before and 1 year after LT were performed as well as liver biopsy 1 year after LT. Results: Of the factors present 1 year after LT, higher ALT (P = 0.021), ALP (P = 0.012) and everolimus treatment (P = 0.025) increased the risk of death at the end of follow-up, borderline significance was found also for higher waist circumference (P = 0.058), AST (P = 0.059), HOMA-IR (P = 0.056) and presence of fibrosis stage ≥3 in biopsy (P = 0.055). In addition to the presence of CKD 1 year after LT (P |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|